Cardinal Health Inc. logo

Cardinal Health Inc. (CAH)

Market Closed
15 Jun, 20:00
NYSE NYSE
$
226. 40
+2.55
+1.1392%
Pre Market
$
227. 20
+0.8 +0.3534%
49.81B Market Cap
164.74 P/E Ratio
2.04% Div Yield
1.76M Volume
5.74 Eps
$ 223.85
Previous Close
Add Transaction
Day Range
221.09 226.66
Year Range
137.75 233.6
Want to track CAH and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Cardinal Health, Inc. (CAH) Citi's 2024 Global Healthcare Conference (Transcript)

Cardinal Health, Inc. (CAH) Citi's 2024 Global Healthcare Conference (Transcript)

Cardinal Health, Inc. (NYSE:CAH ) Citi's 2024 Global Healthcare Conference Call December 3, 2024 8:00 AM ET Company Participants Aaron Alt - Chief Financial Officer Matt Sims - Head, Investor Relations Conference Call Participants Daniel Grosslight - Citi Daniel Grosslight Thanks for joining us for the Cardinal Health fireside chat here at Citi's Global Healthcare Conference. My name is Daniel Grosslight.

Seekingalpha | 1 year ago
Should Value Investors Buy Cardinal Health (CAH) Stock?

Should Value Investors Buy Cardinal Health (CAH) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks | 1 year ago
CAH Stock Gains on the Launch of Kendall SmartFlow Compression System

CAH Stock Gains on the Launch of Kendall SmartFlow Compression System

Cardinal Health launches the next generation of the Kendall Compression Series, Kendall SCD SmartFlow Compression System, to aid pain relating to venous stasis.

Zacks | 1 year ago
Cardinal Health, Inc. (CAH) UBS Global Healthcare Conference (Transcript)

Cardinal Health, Inc. (CAH) UBS Global Healthcare Conference (Transcript)

Cardinal Health, Inc. (NYSE:CAH ) UBS Global Healthcare Conference November 12, 2024 11:00 AM ET Company Participants Matt Sims - Vice President, Investor Relations Aaron Alt - Chief Financial Officer Conference Call Participants Kevin Caliendo - UBS Kevin Caliendo Good morning, everybody. Welcome to the UBS Healthcare Global Healthcare Conference.

Seekingalpha | 1 year ago
Cardinal Health Stock Gains Following Two Strategic Acquisitions

Cardinal Health Stock Gains Following Two Strategic Acquisitions

CAH announces two strategic acquisitions to strengthen its multi-specialty and at-Home Solutions businesses.

Zacks | 1 year ago
Is Cardinal Health (CAH) Outperforming Other Medical Stocks This Year?

Is Cardinal Health (CAH) Outperforming Other Medical Stocks This Year?

Here is how Cardinal Health (CAH) and Adaptive Biotechnologies (ADPT) have performed compared to their sector so far this year.

Zacks | 1 year ago
Are Investors Undervaluing Cardinal Health (CAH) Right Now?

Are Investors Undervaluing Cardinal Health (CAH) Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks | 1 year ago
Cardinal Health buys GI Alliance and Advanced Diabetes Supply Group for about $3.9 bln

Cardinal Health buys GI Alliance and Advanced Diabetes Supply Group for about $3.9 bln

Cardinal Health said on Monday it acquired majority stakes in GI Alliance and Advanced Diabetes Supply Group (ADSG) for about $2.8 billion and $1.1 billion each in an all cash deal.

Reuters | 1 year ago
Cardinal Health Q1 Earnings: Margins Signal More Upside

Cardinal Health Q1 Earnings: Margins Signal More Upside

Cardinal Health's Q1 2025 earnings reaffirm my buy rating due to a strengthening pharmacy business and industry tailwinds. Despite initial market overreaction to 2025 guidance, Cardinal Health's management is transparently mitigating risks. A DCF analysis suggests a price target of $128 for CAH stock, offering a 17% upside.

Seekingalpha | 1 year ago
Cardinal Health, Inc. (CAH) Soars to 52-Week High, Time to Cash Out?

Cardinal Health, Inc. (CAH) Soars to 52-Week High, Time to Cash Out?

Cardinal (CAH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Zacks | 1 year ago
Cardinal Health Stock Hits All-Time High as Existing Customers Power Results

Cardinal Health Stock Hits All-Time High as Existing Customers Power Results

Cardinal Health (CAH) shares hit a new all-time intraday high Friday as the healthcare products provider posted better-than-expected results and raised its outlook even as it took a financial hit from the ending of a big contract.

Investopedia | 1 year ago
Cardinal Health, Inc. (CAH) Q1 2025 Earnings Call Transcript

Cardinal Health, Inc. (CAH) Q1 2025 Earnings Call Transcript

Cardinal Health, Inc. (NYSE:CAH ) Q1 2025 Earnings Conference Call November 1, 2024 8:30 AM ET Company Participants Matt Sims - Vice President, Investor Relations Jason Hollar - Chief Executive Officer Aaron Alt - Chief Financial Officer Conference Call Participants Lisa Gill - JPMorgan Michael Cherny - Leerink Partners Erin Wright - Morgan Stanley Eric Percher - Nephron Research Allen Lutz - Bank of America Kevin Caliendo - UBS Eric Coldwell - Baird George Hill - Deutsche Bank Stephanie Davis - Barclays Elizabeth Anderson - Evercore ISI Daniel Grosslight - Citi Charles Rhyee - TD Cowen Stephen Baxter - Wells Fargo Operator Hello, and welcome to the First Quarter Fiscal Year 2025 Cardinal Health, Incorporated Earnings Conference Call. My name is George, and I'll be your coordinator for today's event.

Seekingalpha | 1 year ago
Loading...
Load More